Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Merck & Co
(NY:
MRK
)
106.45
+1.41 (+1.34%)
Official Closing Price
Updated: 1:10 PM EST, Dec 24, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
5,334,385
Open
105.36
Bid (Size)
106.01 (500)
Ask (Size)
107.00 (1,200)
Prev. Close
105.04
Today's Range
105.28 - 106.95
52wk Range
73.31 - 105.84
Shares Outstanding
2,531,374,696
Dividend Yield
3.04%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Moderna (MRNA) Deep-Dive: Navigating the 7.5% Year-End Slide and the Path to a 2028 Recovery
Today 10:37 EST
As of December 24, 2025, Moderna, Inc. (Nasdaq: MRNA) finds itself at a pivotal crossroads in its corporate evolution. Once the definitive success story of the pandemic era, the Cambridge-based...
Via
PredictStreet
Topics
Initial Public Offering
Sanofi’s $2.2 Billion Strategic Pivot: Deconstructing the Dynavax Acquisition and the Future of Specialty Medicine
Today 10:23 EST
As of today, December 24, 2025, the global pharmaceutical landscape is witnessing a profound consolidation of power within specialty medicine and immunology. Sanofi (NASDAQ: SNY; Euronext: SAN), the...
Via
PredictStreet
Topics
Artificial Intelligence
Economy
Intellectual Property
Performance
YTD
+7.3%
+7.3%
1 Month
+6.0%
+6.0%
3 Month
+33.1%
+33.1%
6 Month
+32.5%
+32.5%
1 Year
+7.1%
+7.1%
More News
Read More
Dynavax Technologies: Analyzing the 39% Surge and Sanofi Acquisition
Today 10:21 EST
Via
PredictStreet
Topics
Economy
Sanofi Acquires Dynavax in $2.2 Billion Christmas Eve Deal, Sending Shares Soaring
Today 10:12 EST
Via
MarketMinute
Topics
Intellectual Property
Top 5 US Healthcare Stocks By Market Value
↗
Today 4:06 EST
Via
Stocktwits
Fitch Sees Stable 2026 Outlook For Global Pharma — But Warns Trump Drug Pricing Push Poses Profit Risk
↗
December 23, 2025
Via
Stocktwits
Topics
Government
The Great Biotech Rebound: How Pricing Clarity Rescued the Drug Sector in 2025
December 23, 2025
Via
MarketMinute
Topics
Economy
SCHD vs. NOBL: Different Paths to Dividend Stability
↗
December 22, 2025
Via
The Motley Fool
Topics
ETFs
The Biotech Renaissance: Innovation and M&A Frenzy Spark a Historic Year-End Rally
December 22, 2025
Via
MarketMinute
Topics
ETFs
Economy
Intellectual Property
The Pfizer Pivot: A Deep-Dive into PFE’s 2025 Financial Recovery and Strategic Rebirth
December 22, 2025
Via
PredictStreet
Topics
Economy
Intellectual Property
Moderna (MRNA): The “Act 2” of an mRNA Pioneer – A 2025 Deep Dive
December 22, 2025
Via
PredictStreet
Topics
Earnings
Initial Public Offering
Intellectual Property
Better Buy in 2026: Pfizer or Merck?
↗
December 19, 2025
Via
The Motley Fool
Topics
Intellectual Property
Trump Strikes New Drug-Price Deals With Roche, Novartis, Merck And Other Pharma Giants
↗
December 19, 2025
Via
Stocktwits
Topics
Government
World Trade
Merck Reaches Agreement With U.S. Government to Expand Access to Medicines and Lower Costs for Americans
December 19, 2025
From
Merck & Co., Inc.
Via
Business Wire
Merck & Co. Inc. (NYSE:MRK) Stands Out as a Durable Dividend Stock
↗
December 19, 2025
Via
Chartmill
AbbVie, Merck, Other Top Drugmakers To Lower Prices Of US Drugs In MFN Deal With Trump Administration: Report
↗
December 19, 2025
Via
Stocktwits
Topics
Economy
Government
This Is the 2nd Priciest Stock Market in 155 Years, Which Makes This High-Yield ETF a Genius Buy for 2026
↗
December 19, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
ETFs
Economy
The 2022 Playbook Returns: Why Investors are Building a 'Fortress 2026'
December 18, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
World Trade
Merck Scores FDA Fast-Track Review For Key Cholesterol And Cancer Drugs With Multibillion-Dollar Potential: Report
↗
December 17, 2025
Via
Stocktwits
Novartis US Stock Rises On Reports Of White House Pricing Deal Due Friday — Roche Also In Talks
↗
December 17, 2025
Via
Stocktwits
Topics
Government
World Trade
The Ultimate High-Yield Drug Stock to Buy With $1,000 Right Now
↗
December 17, 2025
Via
The Motley Fool
Topics
Intellectual Property
KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) Significantly Improved Event-Free Survival, Overall Survival and Pathologic Complete Response Rates for Cisplatin-Eligible Patients with MIBC When Given Before and After Surgery
December 17, 2025
From
Merck & Co., Inc.
Via
Business Wire
Stock Market Today, Dec. 16: Pfizer Falls After Cutting 2025 Revenue Forecast
↗
December 16, 2025
Via
The Motley Fool
Topics
Intellectual Property
Stocks
Pfizer's Muted 2026 Outlook Sends Ripples Through Pharmaceutical Sector
December 16, 2025
Via
MarketMinute
Topics
Intellectual Property
Should You Buy the 5 Highest-Paying Dividend Stocks in the Dow Jones Before 2026?
↗
December 16, 2025
Via
The Motley Fool
Topics
Bonds
Economy
Intellectual Property
Frequently Asked Questions
Is Merck & Co publicly traded?
Yes, Merck & Co is publicly traded.
What exchange does Merck & Co trade on?
Merck & Co trades on the New York Stock Exchange
What is the ticker symbol for Merck & Co?
The ticker symbol for Merck & Co is MRK on the New York Stock Exchange
What is the current price of Merck & Co?
The current price of Merck & Co is 106.45
When was Merck & Co last traded?
The last trade of Merck & Co was at 12/24/25 01:10 PM ET
What is the market capitalization of Merck & Co?
The market capitalization of Merck & Co is 269.46B
How many shares of Merck & Co are outstanding?
Merck & Co has 269B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
